Navigation Links
Measurement Specialties, Inc. Announces Impact of 'German Business Tax Reform 2008' Resulting in Lower Combined German Tax Rate - Impacts 2Q08 Reported Financial Results
Date:10/30/2007

HAMPTON, Va., Oct 30 /PRNewswire-FirstCall/ -- Measurement Specialties, Inc. (Nasdaq: MEAS), a designer and manufacturer of sensors and sensor-based systems, announces the impact of the recently adopted German Business Tax Reform 2008 on current year financial statements.

The German Business Tax Reform 2008, which became effective on August 17, 2007, reduces the corporate income tax rate in Germany, resulting in a reduction in the combined German tax rate from approximately 39% to 31%. Although this tax rate change will have a favorable impact on tax expense associated with profits earned in Germany in FY08 and beyond, the Company is required by financial accounting standards to revalue its net deferred tax asset due to this change.

The Company's net deferred tax asset in Germany is primarily due to the tax benefit resulting from the Net Operating Loss carry-forward acquired through the purchase of HL Planartechnik in November 2005. As a result of the new tax reform and associated decrease in effective tax rate in Germany, the value of the deferred tax asset has been reduced by approximately $1 million, from $4.3 million to $3.3 million. This charge will be reflected in the Company's second quarter results.

Mark Thomson, Company CFO commented, "While this tax rate change is expected to result in an additional income tax expense of approximately 7 cents per diluted share in the second quarter of FY08, this is a discrete, non-cash income tax expense driven by the revaluation of the net deferred tax asset, and will help to lower our overall effective tax rate in future years as our profits in Germany increase as a percent of total global earnings. Other than the impact of the discrete non-cash adjustmen
'/>"/>

SOURCE Measurement Specialties, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Measurement Challenges In Detecting Cancer Biomarkers
2. Errors in the measurement of global warming corrected
3. Wiley announces publication of Databasing the Brain
4. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
5. FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
6. Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis
7. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
8. Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
9. GlycoFi announces the first production of antibodies with human glycosylation in yeast
10. NHGRI announces new sequencing targets
11. CHAVI announces international search for genes affecting HIV response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... premium fruit increases, growers are being challenged to ... boost their bottom line, orchard owners are experimenting ... while reducing labor costs. , Hand thinning, a ... healthier fruit, is among the most labor-intensive of ... production overhead, and, ultimately, prices paid by consumers. ...
(Date:12/11/2009)... Scientists studying how bacteria under stress collectively weigh and ... insights into how humans make strategic decisions that affect ... society. , Their study, published this week in the ... the National Academy of Sciences , was accomplished when ... to describe the complex interplay of genes and proteins ...
(Date:12/11/2009)... two decades, Ivy Pike, an associate professor of anthropology ... groups in rural northern Kenya to understand how violence ... there. , The results of her and her colleagues, ... three pastoralist communities of northern Kenya: A conceptual framework," ... Social Science and Medicine , in collaboration with the ...
Breaking Biology News(10 mins):Horizontal string trimmer reduces labor costs, increases peach size 2Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5UA-led study grapples with health effects of low-intensity warfare 2WebMD Announces Third Quarter Financial Results 60617 1WebMD Announces Third Quarter Financial Results 60617 2WebMD Announces Third Quarter Financial Results 60617 3WebMD Announces Third Quarter Financial Results 60617 4WebMD Announces Third Quarter Financial Results 60617 5WebMD Announces Third Quarter Financial Results 60617 6WebMD Announces Third Quarter Financial Results 60617 7WebMD Announces Third Quarter Financial Results 60617 8WebMD Announces Third Quarter Financial Results 60617 9WebMD Announces Third Quarter Financial Results 60617 10WebMD Announces Third Quarter Financial Results 60617 11WebMD Announces Third Quarter Financial Results 60617 12WebMD Announces Third Quarter Financial Results 60617 13WebMD Announces Third Quarter Financial Results 60617 14WebMD Announces Third Quarter Financial Results 60617 15WebMD Announces Third Quarter Financial Results 60617 16WebMD Announces Third Quarter Financial Results 60617 17WebMD Announces Third Quarter Financial Results 60617 18WebMD Announces Third Quarter Financial Results 60617 19WebMD Announces Third Quarter Financial Results 60617 20WebMD Announces Third Quarter Financial Results 60617 21WebMD Announces Third Quarter Financial Results 60617 22WebMD Announces Third Quarter Financial Results 60617 23United American Nurses Vote Brings Super Union and New Chapter for RN Power Closer to Achievement 60614 1United American Nurses Vote Brings Super Union and New Chapter for RN Power Closer to Achievement 60614 2United American Nurses Vote Brings Super Union and New Chapter for RN Power Closer to Achievement 60614 3Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 1Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 2Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 3Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 4Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 5Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 6Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 7Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 8Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 9Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 10Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 11Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results 3B Nexavar Global Net Sales Top 24229 Million 27 25 Increase Over Third Quarter 20 60611 12
... Chicago show how the bacteria that cause the plague manage ... one of the microbe's tools, the researchers produced what may ... -- one published online July 28 in Science Express and ... focus on aspects of the type-III pathway, a molecular syringe ...
... crop plants, scientists have deciphered the genome of a ... , The research provides clues to better explain how ... and seeds from infection by harmful microbes that cause ... Nature Biotechnology and was scheduled to be posted online ...
... of exactly how the brain controls breathing is fundamental ... breathing is an automatic rhythmic process that persists without ... the question that has intrigued many scientists for well ... safe vital rhythm throughout life? , Experimental Physiology editor ...
Other Biology News:Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine 2Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine 3Studies reveal how plague disables immune system, and how to exploit the process to make a vaccine 4Genome study of beneficial microbe may help boost plant health 2How exactly does the brain control breathing? 2
(Date:12/15/2009)... the launch of several innovative new programs to aid ... current economic climate. The first is aimed at ... services over a period of 6, 12, 18, or ... companies. The second is aimed at more established ... 6 to 12 month period at discounted rates, and ...
(Date:12/14/2009)... Dec. 14 The third edition of ... , published by the Infusion Nurses ... for anthracycline extravasation.(1) Anthracyclines are a group ... epirubicin that have been used in the treatment ... 1970s.(2) ,, According to the INS ...
(Date:12/14/2009)... completed the delivery of Brookfield Engineering’s Powder Flow Tester – ... with a smaller footprint and more compact design. , ... ... -- ThermoFab, a US-based thermoforming company, has completed the delivery ... from sheet metal to a plastic enclosure with a smaller ...
(Date:12/11/2009)... 2009 -- Researchers have discovered a new explanation for differences ... excess copies of a certain gene, the more serious the ... it is suspected that it is the amount of copies ... being published in the American Journal of Human Genetics ... of Guy Froyen connected to VIB, a life sciences research ...
Breaking Biology Technology:The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2Amount of gene surplus determines severity of mental retardation in males 2
... months back I wrote about the negative effects of what ... problems in business can be solved by changing the way ... process management view of sorting out problems is simple ... as designed or wasnt designed properly in the first place. ...
... Red blood cells, some of which are affected by ... Wis. Third Wave Technologies , a Madison-based ... it has sued the California-based Stratagene Corp. ... it has patented the technology used in Stratagenes probe-based ...
... lunch in Chicago on Ontario Street with my young friend Jessica. ... she is six months into her first full-time job and already ... job lacks is career advancement, she told me. So this headhunter ... them about career advancement. She didnt even want me to use ...
Other Biology Technology:Human networks: an antidote to process ideology 2Human networks: an antidote to process ideology 3Human networks: an antidote to process ideology 4Third Wave files patent infringement suit against Stratagene 2Don't be muzzled in your Midwest technology job search 2Don't be muzzled in your Midwest technology job search 3
Puromycin resistance gene (pac), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
...
... template is designed to allow neomycin/kanamycin ... The loxP-PGK-gb2-neo-loxP template encodes the ... prokaryotic promoter (gb2) for expression of ... eukaryotic promoter (PGK) for expression of ...
... precision 5mm diameter, 7 inch long PYREX NMR ... compatibility with ground joints, valves, and vacuum racks. ... running from 300 to 500MHz. They have an ... of 4.20 + 0.013-0.000mm. These NMR tubes can ...
Biology Products: